DFDBA
OtherDemineralized Freeze Dried Allograft bone
Other names: Demineralized Bone Matrix
NCT Number: NCT00255970
The purpose of this research study was to determine whether treatment with the bone grafting material Regenafil was as effective as the standard treatment using demineralized freeze dried bone allograft (DFDBA). Regenafil is demineralized freeze dried bone in a special gel form.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Phase 2 / Phase 3
Indiana University School of Dentistry, Indianapolis, Indiana, United States
To compare the regenerative effects of a demineralized freeze dried bone allograft (DFDBA) particulate in a biologic thermoplastic carrier (Regenafil) to the standard of care. To compare the regenerative effects of a demineralized freeze dried bone allograft (DFDBA) particulate in the treatment of intraosseous vertical defects following six months of healing. This was accomplished by evaluating clinical parameters including probing depth, attachment level and bleeding upon probing, using attachment level as the primary outcome variable.
Treatment of the vertical osseous defect is a challenging problem in periodontics. There are many treatment options including:
Choice of treatment may depend on the defect depth and configuration. A shallow, narrow 3 wall defect may respond well to open flap debridement while a deep 2 wall defect may need regenerative therapy such as an osseous graft, a membrane or combined membrane and graft treatment. Studies of vertical defect therapy with defects about 4 mm or greater show that similar percent defect fill results are obtained with regenerative therapies. Open flap debridement produces substantially less percent defect fill.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Demineralized Freeze Dried Allograft bone
Other names: Demineralized Bone Matrix
Demineralized Freeze Dried Bone in a porcine gel carrier
Other names: Demineralized Freeze Dried Bone Allograft
Time frame: baseline and then at 6 months
This is the distance, measured in millimeters (mm) from the gingival margin to the maximal penetration of the probe tip. The measures were made at baseline and then at 6 months after treatment.
Time frame: 6 months
The amount of space between attached periodontal tissues and a fixed point, usually the cementoenamel junction. A measurement used to assess the stability of attachment as part of a periodontal maintenance program.
Time frame: 6 months
CEJ to gingival margin (GM). GM coronal to the CEJ were scored as a negative number.
Time frame: 6 months
Scores:
0 Normal gingiva
Time frame: 6 months
0- No plaque
Time frame: 6 months
The variable measured the presence of bleeding when the osseus defect was probed. The presence and character of gingival bleeding will be determined by gently probing to the base of the pockets.
0 - No bleeding.
1 - Bleeding when probing.
Time frame: 6 months
Tooth mobility was recorded using Miller's Index:
RTI Surgical
Industry
Regenerative Therapy for Vertical Defects Comparing Demineralized Freeze Dried Bone Allograft (DFDBA) and Regenafil
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07642037
Dental Deposits, Dental Plaque
Sibiu, Sibiu County, Romania
View Trial DetailsNCT07697209
Alveolar Bone Loss, Bone Diseases
Al Mansurah, Egypt
View Trial DetailsNCT07689552
Mouth Diseases, Periodontal Diseases
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07691060
Arachnodactyly, Congenital Abnormalities
Ankara, Turkey (Türkiye)
View Trial Details